Molecular stratification of early breast cancer identifies drug targets to drive stratified medicine
Genetics: Expression signature identifies high-risk patients A gene expression signature identifies breast cancer patients who do poorly after endocrine therapy and might benefit from extra treatment. A team led by John Bartlett and Paul Boutros from the Ontario Institute for Cancer Research in Toro...
Saved in:
Main Authors: | Jane Bayani, Cindy Q. Yao, Mary Anne Quintayo, Fu Yan, Syed Haider, Alister D’Costa, Cassandra L. Brookes, Cornelis J. H. van de Velde, Annette Hasenburg, Dirk G. Kieback, Christos Markopoulos, Luc Dirix, Caroline Seynaeve, Daniel Rea, Paul C. Boutros, John M. S. Bartlett |
---|---|
Format: | article |
Language: | EN |
Published: |
Nature Portfolio
2017
|
Subjects: | |
Online Access: | https://doaj.org/article/e8e3e37c9ac342eb853c51e4f6f7efcc |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative survival analysis of multiparametric tests—when molecular tests disagree—A TEAM Pathology study
by: John M. S. Bartlett, et al.
Published: (2021) -
Pathway-based subnetworks enable cross-disease biomarker discovery
by: Syed Haider, et al.
Published: (2018) -
Stratified coastal ocean interactions with tropical cyclones
by: S. M. Glenn, et al.
Published: (2016) -
Using nuclear receptor activity to stratify hepatocarcinogens.
by: Imran Shah, et al.
Published: (2011) -
On-chip spectrometers using stratified waveguide filters
by: Ang Li, et al.
Published: (2021)